Status:
RECRUITING
Novel Medical Device for Pharmacological Therapy
Lead Sponsor:
Fundacion Miguel Servet
Conditions:
Vascular Access
Vascular Access Complication
Eligibility:
All Genders
1+ years
Phase:
NA
Brief Summary
Background: Different co-creation methods were used to design and prototype a new fixative device for multiple intravenous therapies with the ability to control and identify the pharmacological therap...
Eligibility Criteria
Inclusion
- patients admitted to the intensive care unit
- patients with authorization to take part in the study
Exclusion
- Patients with pre-existing medical conditions: Patients with diseases affecting coagulation, such as hemophilia or thrombocytopathies, could be excluded.
- Active infection patients: Any patient with vascular access site infections or systemic infections may be excluded to avoid complications.
- Inability to give informed consent: Patients who are unable to understand or consent to participate in the study.
Key Trial Info
Start Date :
January 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2026
Estimated Enrollment :
262 Patients enrolled
Trial Details
Trial ID
NCT06938750
Start Date
January 20 2023
End Date
September 20 2026
Last Update
April 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario de Navarra
Pamplona, Navarre, Spain, 31005